Company / SG&A per Share
Vericel SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.36
FY2025
5-year range
$1.33 / $3.36
FY2021-FY2025
Trend
+12.7%
vs FY2024
Sector context
#53 of 210
Health Care
What the data says
Vericel's sg&a per share of $3.36 is higher than 75% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 9 consecutive years, from $0.58 in FY2016 to $3.36 in FY2025.
Based on SEC 10-K filings.
3.36 in FY2025 with a 5-year CAGR of +25.2%. Top quartile in the Health Care sector.
Increased from $2.56 to $3.36 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +31.8%
- 5-Year CAGR
- +25.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 210This company $3.36 Sector average $40.75
▼
-91.7% below sector average
Key checks
Key Insights
- Vericel's sg&a per share has grown for 9 consecutive years.
- In FY2025, sg&a per share increased 12.7% year-over-year.
- Ranks #53 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.36 | +12.7% |
| FY2024 | $2.99 | +16.6% |
| FY2023 | $2.56 | +74.4% |
| FY2022 | $1.47 | +10.0% |
| FY2021 | $1.33 | +22.2% |
| FY2020 | $1.09 | +33.7% |
| FY2019 | $0.82 | +7.0% |
| FY2018 | $0.76 | +7.3% |
| FY2017 | $0.71 | +22.9% |
| FY2016 | $0.58 | +134.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026